Treatment and Follow-up for Pleuritis
The treatment of pleuritis should be directed at the underlying cause, with appropriate antibiotics for infectious etiologies, anti-inflammatory medications for pain relief, and drainage procedures for complicated cases. 1
Diagnostic Approach
- Thorough evaluation is necessary to determine the underlying cause of pleuritis, as treatment and prognosis depend on etiology 2
- Ultrasound is the preferred initial imaging modality for suspected pleural effusion and can help distinguish between exudative and transudative effusions 1
- CT scanning provides comprehensive thoracic assessment and may help differentiate between benign and malignant causes of pleural disease 1
- Diagnostic thoracentesis should be performed within 24 hours in cases of suspected pleural infection 1
Treatment Based on Etiology
Infectious Pleuritis
Antibiotic therapy:
- For community-acquired pleural infections: second-generation cephalosporins (e.g., cefuroxime) or aminopenicillins (e.g., amoxicillin) plus anaerobic coverage with metronidazole 1
- For hospital-acquired infections: broader spectrum antibiotics such as piperacillin-tazobactam, ceftazidime, or meropenem 1
- Antibiotics should be guided by culture results when available 1
- Aminoglycosides should be avoided due to poor pleural penetration 1
Drainage procedures:
- Small-bore chest tubes (14F or smaller) are recommended for initial drainage of infected pleural effusions 1
- For complicated parapneumonic effusions or empyema with persistent collections after initial drainage, combination tissue plasminogen activator (TPA) and DNase should be considered 1
- The recommended regimen is 10 mg TPA twice daily plus 5 mg DNase twice daily for 3 days 1
- Single-agent fibrinolytics or streptokinase are not recommended 1
Surgical intervention:
Non-infectious Inflammatory Pleuritis
Anti-inflammatory medications:
Treatment of underlying conditions:
COVID-19 Associated Pleuritis
- Supportive care with supplemental oxygen as needed 3
- Consider COVID-19 in patients presenting with pleuritic chest pain, even in the absence of typical respiratory symptoms 3
Follow-up Recommendations
For infectious pleuritis:
For nonspecific pleuritis (NSP):
- Extended follow-up is crucial as up to 15% of patients with initial nonspecific pleuritis findings may subsequently develop pleural malignancy, most commonly mesothelioma 1
- Median time to malignant diagnosis is approximately 12 months (range 0.8-32 months) 5
- More vigilant follow-up for patients with asbestos exposure history 5
- Consider repeat biopsies if clinical suspicion for malignancy remains high 1
For post-surgical or post-transplant pleuritis:
Special Considerations
- In cases of nonspecific pleuritis where malignancy is suspected but initial biopsies are negative, long-term radiological monitoring is recommended 1
- For refractory cases with recurrent effusions not responding to conventional therapy, pleurodesis with agents such as minocycline may be considered 6
- Patients with persistent pleural collections and ongoing sepsis should undergo further radiological imaging to guide management 1
- Be mindful of alternative diagnoses that can mimic parapneumonic effusions with low pH and potential for loculations (e.g., rheumatoid effusion, advanced malignancy) 1